Evidence map›Paper›PMID 25479136›Full record

ArticleGastroenterology2015

Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome.

Nam-Joon Cho, Choongho Lee, Phillip S Pang, Edward A Pham, Benjamin Fram, Khanh Nguyen, Anming Xiong, Ella H Sklan, Menashe Elazar, Elif S Koytak and 4 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Exploiting Connections for Viral Replication.Frontiers in cell and developmental biology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Nam-Joon ChoDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.
Choongho LeeDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Phillip S PangDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California.
Edward A PhamDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California.
Benjamin FramDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.
Khanh NguyenDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.
Anming XiongDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.
Ella H SklanDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Menashe ElazarDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.
Elif S KoytakDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Caroline KerstenDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Kay K KanazawaDepartment of Chemical Engineering, Stanford University, Stanford, California.
Curtis W FrankDepartment of Chemical Engineering, Stanford University, Stanford, California.
Jeffrey S GlennDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California; Veterans Administration Medical Center, Palo Alto, California. Electronic address: jeffrey.glenn@stanford.edu.
Stanford University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Translational Incubator CoreU19AI109662 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2014 to 2019
$28.6M
MOLECULAR BASIS OF HOST-PARASITE INTERACTIONT32AI007328 · NIAID · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 1987 to 2026
$11.9M
The PIP2-virus interface and PI 4-kinase: novel biology and validation targetsR01AI099245 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2012 to 2016
$5.2M
HCV NS4B: Translating molecular virology into novel antiviral therapiesR01AI087917 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2010 to 2014
$2.0M
HCV NS5A: Molecular Virology and Antiviral TargetR01DK064223 · NIDDK · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2004 to 2010
$1.5M
Structure-function determination of the Hepatitis C Virus negative RNA strand's 3'-terminal sequenceF30DK099017 · NIDDK · STANFORD UNIVERSITY · PI PHAM, EDWARD ANHOA · 2013 to 2015
$98k
NIAID NIH HHS R01 AI087917NIAID NIH HHS R01 AI099245NIAID NIH HHS T32 AI007328NIAID NIH HHS T32 AI070502NIAID NIH HHS U19 AI109662NIAID NIH HHS U19AI109662NIDDK NIH HHS F30 DK099017NIDDK NIH HHS R01 DK064223NIGMS NIH HHS T32 GM007365
6 · The paper itself

Abstract

BACKGROUND &

aimsPhosphoinositides (PIs) bind and regulate localization of proteins via a variety of structural motifs. PI 4,5-bisphosphate (PI[4,5]P2) interacts with and modulates the function of several proteins involved in intracellular vesicular membrane trafficking. We investigated interactions between PI(4,5)P2 and hepatitis C virus (HCV) nonstructural protein 5A (NS5A) and effects on the viral life cycle.

methodsWe used a combination of quartz crystal microbalance, circular dichroism, molecular genetics, and immunofluorescence to study specific binding of PI(4,5)P2 by the HCV NS5A protein. We evaluated the effects of PI(4,5)P2 on the function of NS5A by expressing wild-type or mutant forms of Bart79I or FL-J6/JFH-5'C19Rluc2AUbi21 RNA in Huh7 cells. We also studied the effects of strategies designed to inhibit PI(4,5)P2 on HCV replication in these cells.

resultsThe N-terminal amphipathic helix of NS5A bound specifically to PI(4,5)P2, inducing a conformational change that stabilized the interaction between NS5A and TBC1D20, which is required for HCV replication. A pair of positively charged residues within the amphipathic helix (the basic amino acid PI(4,5)P2 pincer domain) was required for PI(4,5)P2 binding and replication of the HCV-RNA genome. A similar motif was found to be conserved across all HCV isolates, as well as amphipathic helices of many pathogens and apolipoproteins.

conclusionsPI(4,5)P2 binds to HCV NS5A to promote replication of the viral RNA genome in hepatocytes. Strategies to disrupt this interaction might be developed to inhibit replication of HCV and other viruses.

Indexed as

Genome, ViralHepatocytesVirus ReplicationCell SurvivalCircular DichroismHepacivirusHumansMicroscopy, FluorescencePhosphatidylinositol 4,5-DiphosphateProtein Structure, SecondaryQuartz Crystal Microbalance Techniquesrab1 GTP-Binding ProteinsRNA-Dependent RNA PolymeraseSequence Analysis, RNAViral Nonstructural ProteinsNS-5 protein, hepatitis C virusPhosphatidylinositol 4,5-Diphosphaterab1 GTP-Binding ProteinsRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsAntiviral StrategiesPhospholipidQCMSignaling Molecule

Identifiers

PMID25479136
PMCPMC4339471
OpenAlexW2028976797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.